Response rates for ketamine in treatment-resistant depression reach 70% in some clinical trials—far higher than trying another traditional antidepressant. You may be a good candidate for ketamine therapy if you’ve tried at least two antidepressants without adequate relief, you’re experiencing severe symptoms that interfere with daily life, and you don’t have medical conditions that would make ketamine unsafe. Individual results vary, and candidacy requires thorough evaluation.
What Treatment-Resistant Really Means
The term “treatment-resistant depression” sounds daunting, but it simply means that standard first-line treatments haven’t provided adequate symptom relief. Treatment resistance is typically defined as failing to respond to at least two different antidepressants, taken at adequate doses for six to eight weeks each.
We also consider someone treatment-resistant if they can’t tolerate the side effects of standard antidepressants. Sexual dysfunction, weight gain, emotional blunting, or severe fatigue aren’t acceptable trade-offs if they prevent you from living the life you want. The same principle applies to treatment-resistant PTSD or chronic pain—you’ve tried standard approaches without sufficient improvement.
The Ideal Ketamine Candidate
People who benefit most from ketamine therapy have given standard treatments a genuine try, are dealing with significant symptoms that affect daily functioning, and are motivated to engage actively in treatment. They have realistic expectations—ketamine is a powerful tool, but it works best as part of a comprehensive treatment approach.
Good candidates also have stable enough life circumstances to attend multiple appointments over several weeks. The typical IV ketamine protocol requires six sessions over two to three weeks. For our patients in rural Montana traveling from Paradise Valley or surrounding areas to our Livingston clinic, this scheduling requires planning.
Medical Considerations That Affect Candidacy
Certain medical conditions require careful evaluation before ketamine treatment. Cardiovascular health is the primary concern—ketamine temporarily increases blood pressure and heart rate. Uncontrolled high blood pressure, recent heart attack, or certain heart rhythm problems need evaluation before treatment. Our anesthesia background means we can evaluate cardiovascular risk and monitor you closely.
Active psychotic disorders are generally considered a contraindication, though bipolar disorder isn’t automatically disqualifying when combined with appropriate mood stabilizers. Substance use disorders require honest conversation—current active misuse typically means deferring treatment, while well-managed past issues may not prevent it.
Pregnancy and breastfeeding mean we’ll recommend alternative treatments. Certain medications interact with ketamine, so we review all your medications during evaluation. Most psychiatric medications are fine to continue, but some require dose adjustments.
Psychiatric Considerations
Beyond the diagnosis of treatment-resistant symptoms, we look at several factors when determining candidacy.
Current suicidal ideation doesn’t disqualify you—ketamine’s rapid anti-suicidal effects make it particularly valuable. However, you need to be safe enough for outpatient treatment. Your history with dissociation matters—some find ketamine’s effects therapeutic, others find them triggering.
Concurrent therapy supports better outcomes. Motivation and readiness for change play a role—ketamine creates windows of opportunity, but you need to be ready to act on them.
The Evaluation Process
Determining candidacy requires a thorough evaluation. At our practice, this includes a comprehensive psychiatric assessment, medical history review with attention to cardiovascular health and substance use, and discussion of practical factors like support system and scheduling.
This evaluation typically takes about an hour. We explain what ketamine involves, what to expect, potential side effects, and alternative options. The goal is to give you the information needed to make an informed decision.
When Ketamine Might Not Be the Best Option
You might not be a good candidate if you haven’t tried standard treatments yet—ketamine is typically reserved for treatment-resistant cases. If your goal is to avoid therapy or medication management, ketamine alone probably won’t give lasting results. When medical conditions make ketamine unsafe, we’ll recommend alternatives. Financial constraints are a real barrier since IV ketamine often isn’t covered by insurance. SPRAVATO® may have insurance coverage for approved indications.
Your Next Steps
If you’re reading this and thinking “this sounds like me,” the next step is a consultation. This doesn’t commit you to treatment—it’s an opportunity to have your questions answered, discuss your specific situation, and determine whether ketamine is a good fit.
We serve adults in Livingston and throughout rural Montana who are dealing with treatment-resistant mental health conditions or chronic pain. Our focus is on combining medical safety with psychiatric expertise to give you the best possible outcomes. We also provide a judgment-free, LGBTQ+ affirming environment where you can discuss your mental health openly.
Deciding to pursue ketamine therapy is a significant step. It means you’re not giving up despite previous treatments not working. It means you’re willing to try something new, even though it’s unfamiliar. That takes courage.
Not everyone is a candidate for ketamine treatment, and that’s okay—there are other options to explore if ketamine isn’t right for you. But if you are a candidate, this treatment could be the breakthrough you’ve been looking for. At Mend The Mind, we’re here to help you figure out if ketamine is your next best step. Call (406) 220-7639 to schedule your consultation and start the conversation about whether this treatment might work for you.
FAQ Section
Q: Do I need to stop my current antidepressants before starting ketamine? A: Usually not. We typically recommend staying on your current medications during ketamine treatment. The combination is generally safe and may provide better results than ketamine alone. We’ll review your specific medications during your evaluation.
Q: How do I know if I’ve tried “enough” treatments to qualify as treatment-resistant? A: The general guideline is at least two different antidepressants at adequate doses for at least six to eight weeks each without sufficient response. If you’ve been through this cycle multiple times, you likely meet criteria for treatment-resistant depression.
Q: Can I try ketamine if I’ve never been on psychiatric medication? A: Ketamine is typically reserved for treatment-resistant cases, meaning you’ve tried standard treatments first. However, in certain situations—like if you can’t tolerate antidepressants due to medical conditions—we might consider ketamine earlier. This requires individualized discussion.
Q: What happens if I’m not a good candidate for ketamine? A: We discuss alternative treatment options during your evaluation. This might include SPRAVATO® if you don’t qualify for IV ketamine, other medications you haven’t tried, TMS (transcranial magnetic stimulation), or intensive outpatient therapy programs.
Conclusion
Being a good candidate for ketamine therapy comes down to having treatment-resistant symptoms that significantly affect your life, being medically appropriate for the treatment, and being ready to engage in the protocol. The best way to find out if you qualify is through a thorough evaluation with a provider experienced in both ketamine therapy and psychiatric care.
If you’re struggling with depression, PTSD, chronic pain, or other conditions that haven’t responded to standard treatments, we can help you determine whether ketamine is a good option. At Mend The Mind, we bring both anesthesia expertise and psychiatric training to every patient evaluation, ensuring your safety and optimizing your chances of success. Reach out at (406) 220-7639 to schedule your consultation.
References
American Psychiatric Nurses Association. (2025). Ketamine Checklist. https://www.apna.org/ketamine-infusion-therapy/
Harvard Health Publishing. (2024). Ketamine for treatment-resistant depression: When and where is it safe? https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
Mayo Clinic Press. (2024). Ketamine for treatment-resistant depression: What you need to know. https://mcpress.mayoclinic.org/living-well/ketamine-for-treatment-resistant-depression-what-you-need-to-know/